Abstract
Duchenne muscular dystrophy leads to progressive deterioration in skeletal and cardiac muscle function. Steroids prolong ambulation and improve respiratory muscle strength. The authors hypothesized that steroid treatment would stabilize cardiac muscle function. Echocardiograms performed from 1997 to 2004 for 111 subjects 21 years of age or younger with Duchenne muscular dystrophy were restrospectively reviewed. The medical record was reviewed for steroid treatment. Untreated and steroids-treated subjects did not differ in age, height, weight, body mass index, systolic and diastolic blood pressure, or left ventricular mass. The shortening fraction was lower in the untreated group. Of those treated, 29 received prednisone and 19 received deflazacort. There was no difference in the shortening fraction between the two treated subgroups. Treated subjects not receiving steroids still had a normal shortening fraction, which was no different from the shortening fraction of those still receiving treatment. As compared with the treated subjects, the untreated subjects 10 years of age or younger were 4.4 times more likely to have a shortening fraction less than< 28% (p = 0.03), and the untreated subjects older than 10 years were 15.2 times more likely to have a shortening fraction less than< 28% (p < 0.01). This retrospective study suggests that the progressive decline in cardiac function of patients with Duchenne muscular dystrophy can be altered by steroid treatment. The effect appears to be sustained beyond the duration of treatment and independent of steroid type.
Similar content being viewed by others
References
WD Biggar M Gingras DL Fehlings VA Harris CA Steele (2001) ArticleTitleDeflazacort treatment of Duchenne muscular dystrophy J Piediatr 138 45–50 Occurrence Handle1:CAS:528:DC%2BD3MXhtF2msr0%3D
BJ Boland PL Silbert RV Groover PC Wollan MD Silverstein (1996) ArticleTitleSkeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy Pediatr Neurol 14 7–12 Occurrence Handle10.1016/0887-8994(95)00251-0 Occurrence Handle1:STN:280:BymB3szhs1c%3D Occurrence Handle8652023
MH Brooke GM Fenichel RC Griggs JR Mendell RT Moxley SuffixIII et al. (1987) ArticleTitleClinical investigation of Duchenne muscular dystrophy: Interesting results in a trial of prednisone Arch Neurol 44 812–817 Occurrence Handle1:STN:280:BiiA38rnsFQ%3D Occurrence Handle3632393
K Bushby F Muntoni A Urtizberea R Hughes R Griggs (2004) ArticleTitleTreatment of Duchenne muscular dystrophy. Defining the gold standards of management in the use of corticosteroids. Report of the 124th ENMC International Workshop Neuromuscul Disord 14 526–534 Occurrence Handle1:STN:280:DC%2BD2cvjt1GrtA%3D%3D Occurrence Handle15336694
AM Connolly J Schierbecker R Renna J Florence (2002) ArticleTitleHigh-dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy Neuromuscul Disord 12 917–925 Occurrence Handle12467746
S DeSilva DB Drachman D Mellits RW Kuncl (1987) ArticleTitlePrednisone treatment in Duchenne muscular dystrophy: Long-term benefit Arch Neurol 44 818–822 Occurrence Handle1:STN:280:BiiA38rnsFU%3D Occurrence Handle3632394
RB Devereux DR Alonso EM Lutas et al. (1986) ArticleTitleEchocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings Am J Cardiol 57 450–458 Occurrence Handle1:STN:280:BimC38jgslw%3D Occurrence Handle2936235
L D’Orsogna JP O’Shea G Mllier (1988) ArticleTitle Cardiomyopathy of Duchenne muscular dystrophy Pediatr Cardiol 96 205–213
HP Gutgesell et al. (1977) ArticleTitleEvaluation of left ventricular size and function by echocardiography: Results in normal children Circulation 56 457–462 Occurrence Handle1:STN:280:CSiB38vgsVU%3D Occurrence Handle884801
SB Heymsfield T McNish JV Perkins JM Felner (1978) ArticleTitleSequence of cardiac changes in Duchenne muscular dystrophy Am Heart J 95 283–294 Occurrence Handle1:STN:280:CSeC3c%2FjsVc%3D Occurrence Handle622971
GW Manning CJ Cropp (1958) ArticleTitleElectrocardiogram in progressive muscular dystrophy Br Heart J 20 416–420 Occurrence Handle1:STN:280:CyeC3czotVw%3D Occurrence Handle13560702
AY Manzur T Kuntzer M Pike A Swan (2004) ArticleTitleGlucocorticoid corticosteroids for Duchenne muscular dystrophy Cochrane Database Syst Rev 2 CD003725 Occurrence Handle15106215
LE Mesa AL Dubrovsky J Corderi P Marco D Flores (1991) ArticleTitleSteroids in Duchenne muscular dystrophy: Deflazacort trial Neuromuscul Disord 1 261–266 Occurrence Handle1:STN:280:By2A2MzntFU%3D Occurrence Handle1822804
JK Perloff AC Leon Particlede SuffixJr D O’Doherty (1996) ArticleTitleThe cardiomyopathy of progressive muscular dystrophy Circulation 33 625–648
JK Perloff WC Roberts AC deLeon D O’Doherty (1967) ArticleTitleDistinctive electrocardiography of Duchenne’s progressive muscular dystrophy: An electrocardiographic–pathologic correlative study Am J Med 42 179–188 Occurrence Handle10.1016/0002-9343(67)90017-4 Occurrence Handle1:STN:280:CCiD1M3ps1A%3D Occurrence Handle6018530
K Sasaki K Sakata E Kachi S Hirata T Ishihara K Ishikawa (1998) ArticleTitleSequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: A two-dimensional echocardiographic study Am Heart J 135 IssueID6 pt 1 937–944 Occurrence Handle1:STN:280:DyaK1c3pt1Snug%3D%3D Occurrence Handle9630096
J Schott M Jacobi MA Wald (1955) ArticleTitleElectrocardiographic patterns in the differential diagnosis of progressive muscular dystrophy Am J Med Sci 229 517–524 Occurrence Handle1:STN:280:CyqD28zgsF0%3D Occurrence Handle14361418
CK Silversides GD Webb VA Harris WD Biggar (2003) ArticleTitleEffects of deflazacort on left ventricular functions in patients with Duchenne muscular dystrophy Am J Cardiol 91 769–772 Occurrence Handle1:CAS:528:DC%2BD3sXhvFeqtbs%3D Occurrence Handle12633823
PL Wahi KC Bhargava S Mohindra (1971) ArticleTitleCardiorespiratory changes in progressive muscular dystrophy Br Heart J 33 533–537 Occurrence Handle1:STN:280:CS6B2M%2FhvF0%3D Occurrence Handle5557466
BL Wong C Christopher (2002) ArticleTitleCorticosteroids in Duchenne muscular dystrophy: A reappraisal J Child Neurol 17 183–190 Occurrence Handle12026233
O Yilmaz A Karaduman H Topaloglu (2004) ArticleTitlePrednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis Eur J Neurol 11 541–544 Occurrence Handle10.1111/j.1468-1331.2004.00866.x Occurrence Handle1:STN:280:DC%2BD2czntVOjtg%3D%3D Occurrence Handle15272899
Author information
Authors and Affiliations
Corresponding author
Additional information
This work is supported by a grant from the Parent Project Muscular Dystrophy.
Rights and permissions
About this article
Cite this article
Markham, L., Spicer, R., Khoury, P. et al. Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy. Pediatr Cardiol 26, 768–771 (2005). https://doi.org/10.1007/s00246-005-0909-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-005-0909-4